Xiuwu C. Bian
No. 29 Gaotanyan Street
Shaping, 400038, China
Shaping, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.
Journal: Stem cell reports
Published: May 21, 2026
Human Organoids Reveal PTEN-Driven Mesendoderm Specification via Retinoic Acid Signaling Suppression.
Journal: Research (Washington, D.C.)
Published: February 11, 2026
Erratum to "Gut Microbiota Modulation by Lysozyme as a Key Regulator of Vascular Inflammatory Aging".
Journal: Research (Washington, D.C.)
Published: January 13, 2026
Pathway-Aware Multimodal Transformer (PAMT): Integrating Pathological Image and Gene Expression for Interpretable Cancer Survival Analysis.
Journal: IEEE transactions on pattern analysis and machine intelligence
Published: September 18, 2025
Molecular alterations prediction in gliomas via an interpretable deep learning model: a multicentre and retrospective study.
Journal: The Lancet. Digital health
Published: July 09, 2025
Cytological Classification Diagnosis for Thyroid Nodules via Multimodal Model Deep Learning.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 19, 2025
Gut Microbiota Modulation by Lysozyme as a Key Regulator of Vascular Inflammatory Aging.
Journal: Research (Washington, D.C.)
Published: March 24, 2025
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer.
Journal: EBioMedicine
Published: December 23, 2024
Author Correction: π-HuB: the proteomic navigator of the human body.
Journal: Nature
Published: December 23, 2024
P-selectin Facilitates SARS-CoV-2 Spike 1 Subunit Attachment to Vesicular Endothelium and Platelets.
P-selectin Facilitates SARS-CoV-2 Spike 1 Subunit Attachment to Vesicular Endothelium and Platelets.
Journal: ACS infectious diseases
Published: June 24, 2024
Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial.
Journal: EClinicalMedicine
Published: December 15, 2023
Last Updated: 09/26/2026